ClinicalTrials.gov
ClinicalTrials.gov Menu

Lenalidomide in Kaposi Disease Associated With HIV Infection (LENAKAP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01282047
Recruitment Status : Terminated
First Posted : January 24, 2011
Last Update Posted : August 1, 2014
Sponsor:
Collaborator:
Celgene Corporation
Information provided by (Responsible Party):
French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) ( French National Agency for Research on AIDS and Viral Hepatitis )